Sort
15,273 grants matching “antimicrobial resistance”
Salmonella-specific therapeutics
$719,497Brian M Ahmer · Ohio State University · R01 · FY2019 · AI
Proteomics-Driven Reverse Vaccinology for Gonorrhea
$719,450Aleksandra Elzbieta Sikora · Oregon State University · R01 · FY2023 · AI
Developmental and Translational Pharmacology of Pediatric Antimicrobial Therapy
$719,439Edmund Vincent Capparelli · University Of California, San Diego · U54 · FY2015 · HD
Bacterial Drug Susceptibility Identification by Surface Enhanced Raman Microscopy
$719,370Alexis F Sauer-Budge · Fraunhofer Center /Manufacturing Innov · R01 · FY2013 · AI
Mechanism and activity of beta-lactam resistant enzymes in E. faecium and E. faecalis
$719,203Louis B. Rice · Rhode Island Hospital · R01 · FY2022 · AI
Sinusitis in Children and the Nasopharyngeal Microbiome
$718,967Ellen R. Wald · University Of Wisconsin-Madison · R01 · FY2014 · AI
Identifying Optimal Antibiotic Regimens to Treat Urinary Tract Infections During Pregnancy
$718,915Anne Mobley Butler · Washington University · R01 · FY2022 · HD
Inhalation Therapy Platform for Coronavirus Infection Treatment
$718,653Patrick S. Stayton · University Of Washington · R01 · FY2024 · AI
Antibacterial inhibitors of RnpA
$718,534Paul M. Dunman · University Of Rochester · R01 · FY2019 · AI
Aging Microbiome, Immunosenescence, and risk of Multi-drug Resistant Organism Colonization and Infection in the Nursing Home
$718,183John Patrick Haran · Univ Of Massachusetts Med Sch Worcester · R01 · FY2023 · AG
A prospective trial of oral azithromycin when added to inhaled tobramycin in CF
$718,089David Paul Nichols · Seattle Children'S Hospital · R01 · FY2016 · HL
Rapid AST through Metabolic Imaging at Single Cell Level
$718,052Ji-Xin Cheng · Boston University (Charles River Campus) · R01 · FY2023 · AI
Dissecting Yersinia Yop Targets in Neutrophils
$717,696Joan C. Mecsas · Tufts University Boston · R01 · FY2024 · AI
Dissecting Yersinia Yop Targets in Neutrophils
$717,696Joan C. Mecsas · Tufts University Boston · R01 · FY2023 · AI
Genomics of S. Aureus Colonization after Initial and Recurrent Skin Infections and the Impact of Antibiotics
$717,379Michael Zdenek David · University Of Pennsylvania · R01 · FY2022 · AI
Development of an antimicrobial peptide therapeutic for Pseudomonas infections
$717,345H. Anne Pereira · University Of Oklahoma Hlth Sciences Ctr · U01 · FY2009 · AI
Integrated modeling of Klebsiella pneumoniae infections based on bacterial genotype, patient factors and colonization status
$717,327Michael Abbott Bachman · University Of Michigan At Ann Arbor · R01 · FY2019 · AI
Antimicrobial resistant E. coli before and after California Senate bill 27 (ARES): a natural experiment
$716,971Sara Tartof · Kaiser Foundation Research Institute · R01 · FY2021 · AI
Novel Imaging Tracers for Rapid and Noninvasive Assessment of Bacterial Infection
$716,727Sanjay Jain · Johns Hopkins University · R01 · FY2014 · EB
Optimization and Lead Selection of Novel Antimycobacterial Agents
$716,061Xicheng Sun · Crestone, Inc. · R44 · FY2016 · GM
Involvement Of Human Viruses Associated With Chronic Neurologic Disease
$715,738Steven Jacobson · National Institute Of Neurological Disorders And Stroke · ZIA · FY2025 · NS
Novel Imaging Tracers for Rapid and Noninvasive Assessment of Bacterial Infection
$715,620Sanjay Jain · Johns Hopkins University · R01 · FY2016 · EB
Regulation of lipid metabolism in bacteria
$715,540Charles O Rock · St. Jude Children'S Research Hospital · R01 · FY2012 · GM
Regulation of lipid metabolism in bacteria
$715,540Charles O Rock · St. Jude Children'S Research Hospital · R01 · FY2014 · GM
Therapeutics Testing In Murine Models of Bacterial Thigh & Lung Infections
$715,130William Weiss · University Of North Texas Hlth Sci Ctr · N02 · FY2017 · AI